Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4105941 Target Snapshot

2-amino-3-carboxymuconate-6-semialdehyde decarboxylase · SINGLE PROTEIN · Homo sapiens

79Compounds
18Assays
2Approved Drugs
93.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q8TDX5. Use UniProt Q8TDX5 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q8TDX5 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase as ChEMBL target CHEMBL4105941, mapped to UniProt Q8TDX5. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
2-amino-3-carboxymuconate-6-semialdehyde decarboxylase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL4105941
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q8TDX5
2-amino-3-carboxymuconate-6-semialdehyde decarboxylase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase is the right protein anchor across sources, using UniProt Q8TDX5 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label2-amino-3-carboxymuconate-6-semialdehyde decarboxylase
UniProt AccessionQ8TDX5
Component TypeProtein
Sequence Length336 aa

2-amino-3-carboxymuconate-6-semialdehyde decarboxylase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase, mapped to UniProt Q8TDX5. Sequence length is 336 aa.

Mapped IDQ8TDX5
Review name2-amino-3-carboxymuconate-6-semialdehyde decarboxylase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
Assay Mix

Activity Type Distribution

IC5091.0
KI2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4072240 8.52 IC50 3.0 Preclinical
CHEMBL4071212 8.0 IC50 10.0 Preclinical
CHEMBL4100715 7.92 IC50 12.0 Preclinical
CHEMBL4796997 7.89 IC50 13.0 Preclinical
CHEMBL4553502 7.6 IC50 25.0 Preclinical
CHEMBL4578242 7.51 IC50 31.0 Preclinical
CHEMBL4067706 7.35 IC50 45.0 Preclinical
CHEMBL4437596 7.31 IC50 49.0 Preclinical
CHEMBL4580504 7.18 IC50 66.0 Preclinical
CHEMBL4097581 7.15 IC50 71.0 Preclinical
Distribution

pChEMBL Value Distribution

8
5.0
12
5.5
8
6.0
6
6.5
28
7.0
10
7.5
4
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

18
Total Assays
74
Tested Compounds
1
Assay Types
Binding — 18 assays, 74 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 10 32 6.9
single protein format 6 17 5.3
assay format 2 25 6.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine